Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

Transforming science into medicine

The focus of the Drug Development Office is on preclinical and early phase clinical studies.

DDO timeline

We carry out:

  • Projects requiring preclinical development, including safety toxicology, drug manufacture and formulation
  • Phase I studies focused on safety data, pharmacokinetics and modulation of target biomarkers
  • Combination trials of unregistered and registered agents
  • Early phase II 'proof of principle' studies focusing on the use of biological endpoints
  • 'Non critical path' studies on agents in active commercial development


Updated: 26 May 2010